Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,200.3
27.3 (0.86%)

 

  • STI Straits Times Index
    3,200.3
    27.3 (0.86%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,587.5
    9.1 (0.58%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,610.7
    -26.8 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,418.9
    -22.4 (-0.65%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,357.8
    26.5 (0.09%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,928.3
    -41.9 (-0.70%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,799.6M
  • Value: 1,479.4M
  • Rise: 165
  • Fall: 169
  • Unch: 435

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.008-
Renaissance United0.003+0.001
ESR-REIT0.390-0.020
Sembcorp Marine0.198-0.002
SPH1.520-0.270
Jiutian Chemical0.100+0.001
VCPlus0.032-0.001
Blumont0.005-
MM2 Asia0.063-
YZJ Shipbldg SGD1.530+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,752.2 +119.4
HSI 28,610.7 -26.8
HSCEI 10,699.0 -57.4
Jakarta 5,928.3 -41.9
Nikkei 225 29,357.8 +26.4
SSE Comp 3,418.9 -22.4
Shanghai A 3,583.5 -23.5
Shanghai B 248.2 -0.4
KOSPI 3,197.2 +18.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IMMUNOVANT INC IMMUNOVANT
Updated on 07 May 2021 (End of trading day)
Last (USD): 16.760 Change: +0.270 High: 16.870 Remarks: -
Change (%): +1.64 Low: 16.430
Open 16.430 Yesterday's Close 16.490000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,430,530 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.67763 Trailing EPS (USD) e -1.01891 NAV (USD) b 4.2273
PE a - Trailing PE f - Price / NAV b 3.9647
Dividend (USD) d - Cash In Hand (USD) g 4.3071 Issued & Paid-up Shares c 97,971,200
Dividend Yield (%) d - Price / Cash In Hand g 3.891 Treasury Shares h -
Market Cap (M) 1,641.997 Enterprise Value (M) 1,223.519
Piotroski F Score 2 Exchange Code IMVT Par Value ( $ ) n.a.
52 Weeks Volatility (%) 82.92 Free Float (%) 41.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Nov 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IMMUNOVANT INC NASDAQ 1,641.997 - - 3.9647 -
Industry Biotechnology NASDAQ 2,878.391 106.306 106.381 6.5246 0.611
Local Peer AMGEN INC NASDAQ 146,057.372 20.107 20.615 15.6479 2.534
Local Peer GILEAD SCIENCES INC NASDAQ 83,441.160 678.357 277.213 4.4000 4.088
Local Peer MODERNA INC NASDAQ 65,289.367 - - 25.4898 -
Local Peer ILLUMINA INC NASDAQ 56,055.240 85.450 88.977 11.3887 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,658.779 20.526 20.151 6.1979 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 52,925.717 15.065 15.065 4.8004 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 44,369.823 2,561.132 2,560.980 26.4339 -
Local Peer BIOGEN INC NASDAQ 41,258.092 10.313 13.699 3.8623 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 37,668.268 62.427 55.248 3.0337 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,608.023 - - 7.3937 -
Local Peer SEAGEN INC NASDAQ 25,314.227 41.251 38.317 7.3918 -
Local Peer INCYTE CORPORATION NASDAQ 18,196.429 - 38.030 6.6706 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VERACYTE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INSTIL BIO INC (NASDAQ), SEER INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), XENCOR INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), OCUGEN INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CYTOKINETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOATLA INC (NASDAQ), ALLOVIR INC (NASDAQ), REGENXBIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), ALECTOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MIMEDX GROUP INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), CORTEXYME INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), NKARTA INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VAXART INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MERUS B V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CHEMOCENTRYX INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), AGENUS INC (NASDAQ), ARDELYX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), COMPUGEN (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INHIBRX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKOUOS INC (NASDAQ), SESEN BIO INC (NASDAQ), ADICET BIO INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), GERON CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ONCORUS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), AVROBIO INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOME INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CHIASMA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOVIE INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), IMV INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), INFLARX N V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ORGENESIS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), OTONOMY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), LUMOS PHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SOLIGENIX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PALISADE BIO INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HISTOGEN INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 124,934.991 39.835 32.828 11.8227 1.069
Global Peer WUXI BIO HKEx 424,178.946 223.510 223.512 17.3972 -
Global Peer BEIGENE HKEx 222,067.547 - - 7.4019 -
Global Peer SINO BIOPHARM HKEx 149,496.915 48.010 48.010 7.5293 0.921
Global Peer ZAI LAB-SB HKEx 112,201.370 - - 12.3748 -
Global Peer JOINN HKEx 36,994.094 104.509 81.946 4.7279 0.241
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer GENSCRIPT BIO HKEx 34,638.744 - - 4.9543 -
Global Peer KINTOR PHARMA-B HKEx 22,817.163 - - 12.7623 -
Other Global Peers NUVATION BIO INC (NYSE), 3SBIO (HKEx), ARCUS BIOSCIENCES INC (NYSE), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), JHBP-B (HKEx), IMUGENE LIMITED (ASX), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), ANTEOTECH LIMITED (ASX), ASCLETIS-B (HKEx), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NEXT SCIENCE LTD (ASX), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), BIOMX INC (NYSE American), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), UNI-BIO GROUP (HKEx), ACTINOGEN MEDICAL LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), RHINOMED LIMITED (ASX), BIOTRON (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), BIOSINO BIO-TEC (HKEx), ADALTA LTD (ASX), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), CRYOSITE (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.080
+6.89 %
10 Days -+1.320
+8.55 %
20 Days -+1.080
+6.89 %
Medium Term Return 3 Months --7.390
-30.60 %
6 Months --32.660
-66.09 %
1 Year --3.480
-17.19 %
Annualised Return Annualised --
-17.19 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.800 - 53.750 Change From 1 Year Low +4.960 % Change From 1 Year Low (%) +42.03
Change From 1 Year High -36.990 % Change From 1 Year High (%) -68.82
2 Years Range 8.340 - 53.750 Change From 2 Years Low +8.420 % Change From 2 Years Low (%) +100.96
Change From 2 Years High -36.990 % Change From 2 Years High (%) -68.82
5 Years Range 8.340 - 53.750 Change From 5 Years Low +8.420 % Change From 5 Years Low (%) +100.96
Change From 5 Years High -36.990 % Change From 5 Years High (%) -68.82
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Immunovant, Inc. is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
07 May 2021 16.430 16.870 16.430 16.760 1,430,530 -
06 May 2021 16.430 16.770 16.220 16.490 823,956 -
05 May 2021 16.220 16.800 16.160 16.400 709,051 -
04 May 2021 16.220 16.420 15.620 16.260 962,931 -
03 May 2021 16.050 16.620 16.020 16.380 761,176 -
30 Apr 2021 16.040 16.380 15.575 15.680 445,850 -
29 Apr 2021 16.310 16.715 15.910 16.300 395,986 -
28 Apr 2021 16.060 16.500 15.890 16.350 465,686 -
27 Apr 2021 15.785 16.300 15.710 16.090 592,271 -
26 Apr 2021 15.410 15.980 15.260 15.930 400,989 -
23 Apr 2021 15.940 16.080 15.330 15.440 336,714 -
22 Apr 2021 15.410 16.250 15.310